Abstract:<span class="a-plus-plus abstract-section id-a-sec1"><h3 class="a-plus-plus">Purpose</h3><p class="a-plus-plus">It has been suggested that restoring gut microbiota alterations with probiotics represents a potential clinical target for the treatment of gut microbiota-related diseases, such as obesity. Here, we apply 16S rDNA microbiota profiling to establish which bacteria in the human gut are associated with obesity and cardiometabolic risk factors, and to evaluate whether probiotic supplementation modulates gut microbiota.</p></span><span class="a-plus-plus abstract-section id-a-sec2"><h3 class="a-plus-plus">Methods</h3><p class="a-plus-plus">We evaluated the effects of a probiotic mixture (2 × 10<sup class="a-plus-plus">10</sup> CFU/day of <em class="a-plus-plus">Lactobacillus acidophilus</em> LA-14, <em class="a-plus-plus">Lactobacillus casei</em> LC-11, <em class="a-plus-plus">Lactococcus lactis</em> LL-23, <em class="a-plus-plus">Bifidobacterium bifidum</em> BB-06, and <em class="a-plus-plus">Bifidobacterium lactis</em> BL-4) in 32 overweight or obese women in a double-blind, randomized, placebo-controlled study. Using 16S rDNA sequencing, we characterized fecal samples and investigated the relationships between microbiome data and diet, body composition, antioxidant enzymes, and inflammatory profile. In addition, we characterized the degree of variation among fecal communities after the intervention.</p></span><span class="a-plus-plus abstract-section id-a-sec3"><h3 class="a-plus-plus">Results</h3><p class="a-plus-plus">BMI, weight, fat mass, lean mass, conicity index, protein intake, monounsaturated fat intake, glycated hemoglobin, TNF-α, and IL6/IL10 were significantly correlated with microbiome composition. The candidate division TM7 was strongly associated with all adiposity markers and <em class="a-plus-plus">Clostridiaceae</em> associated negatively with TNF-α. The family <em class="a-plus-plus">Clostridiaceae</em> increased and TM7 tended to decrease after the probiotic mixture supplementation. Subjects were clustered according to body composition, and a higher proportion of TM7 was observed in those with higher adiposity.</p></span><span class="a-plus-plus abstract-section id-a-sec4"><h3 class="a-plus-plus">Conclusions</h3><p class="a-plus-plus">Ecosystem-wide analysis of probiotic use effects on the gut microbiota revealed a genera specific influence, and one of which (TM7) represents a promising novel target for obesity treatment.</p></span><span class="a-plus-plus abstract-section id-a-sec5"><h3 class="a-plus-plus">Trial registration number</h3><p class="a-plus-plus">U1111-1137-4566.</p></span>

Gut microbiota is associated with adiposity markers and probiotics may impact specific genera